CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 29, 2025	Mar. 30, 2024
OPERATING ACTIVITIES
Net income	$ 43,571	$ 48,452
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	18,430	16,668
Amortization of intangibles	14,331	15,825
Deferred revenue	613	(918)
Impairment charges	136	933
Stock-based compensation	4,855	3,617
Loss on investments and other assets	1,630	379
Deferred income taxes	(2,916)	(8,811)
Other	579	1,036
Changes in operating assets and liabilities:
Trade receivables	(14,745)	(12,723)
Inventories	8,699	16,179
Accounts payable	(8,772)	345
Accrued liabilities and income taxes	(8,044)	(28,042)
Prepaid expenses and other assets	7,391	4,210
Net cash provided by operating activities	65,758	57,150
INVESTING ACTIVITIES
Acquisitions of businesses, net of cash acquired	(57,417)	0
Purchases of property, plant, and equipment	(23,102)	(15,547)
Net proceeds from sale of property, plant and equipment, and other	11	7,064
Net cash used in investing activities	(80,508)	(8,483)
FINANCING ACTIVITIES
Payments of senior notes payable	(50,000)	0
Repayments of other debts	(657)	(678)
Payments of term loan	(3,750)	(1,875)
Net proceeds related to stock-based award activities	2,082	1,364
Repurchases of common stock	(27,374)	(16,131)
Cash dividends paid	(17,335)	(16,200)
Net cash used in financing activities	(97,034)	(33,520)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	5,603	(8,550)
(Decrease) increase in cash, cash equivalents, and restricted cash	(106,181)	6,597
Cash, cash equivalents, and restricted cash at beginning of period	726,437	557,123
Cash, cash equivalents, and restricted cash at end of period	620,256	563,720
Reconciliation of cash and cash equivalents:
Cash and cash equivalents	618,687	562,153
Restricted cash included in other long-term assets	1,569	1,567
Cash paid during the period for interest	12,193	13,235
Capital expenditures, not yet paid	$ 4,952	$ 9,968